Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
Clinical trial NCT05794425 · UNKNOWN
Trial details
- NCT number
- NCT05794425
- Sponsor
- Shandong Qilu Stem Cells Engineering Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-04-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.